Interestingly, the same study showed that pancreatic cancer patients with increased co-expression of LC3 and ALDH1 correlated with poor Progression Free Survival (PFS) and worse Overall Survival (OS). This evidence concerns the gene ALDH1A1 and familial pancreatic carcinoma.